On December 5, Senators Warren and Grassley sent a letter to the Acting FDA Commissioner, Brett Giroir, MD, pointing out the fact that the FDA previously announced that over-the-counter (OTC) hearing aid rules would be a priority on their fall 2018 Unified Agenda and they would likely deliver the proposed rules well in advance of the August 2020 statutory deadline. Senators Warren and Grassley note that “it is now December 2019 and we have yet to see these regulations come to fruition.”
Citing the serious nature of hearing difficulties and the related conditions that frequently accompany them, the letter requests that the FDA provide an update on the status of the OTC hearing aid rules and regulations and when the FDA expects to finalize the OTC hearing aid rules no later than December 19, 2019.
Recent Posts
Dizziness and Neck Pain: A Perspective on Cervicogenic Dizziness
Cervicogenic dizziness is a somewhat controversial topic, as this condition is often considered a diagnosis of exclusion without a specific objective standardized test across health-care…
Audiologists Advocate for Fair Use of “Doctor” Title in Florida
This week, the American Academy of Audiology, in collaboration with the Florida Academy of Audiology (FLAA), voiced concerns about House Bill (HB) 1341—legislation that would…
Arkansas Enacts Law Expanding Audiologists’ Scope of Practice
Arkansas Senate Bill 118 has been signed into law, updating the state’s audiology scope of practice statute. The law allows audiologists who are licensed to…
